22.79
0.31%
0.07
After Hours:
22.79
Phreesia Inc stock is traded at $22.79, with a volume of 340.58K.
It is up +0.31% in the last 24 hours and down -11.36% over the past month.
See More
Previous Close:
$22.72
Open:
$22.52
24h Volume:
340.58K
Relative Volume:
0.87
Market Cap:
$1.33B
Revenue:
$356.30M
Net Income/Loss:
$-136.89M
P/E Ratio:
-7.9685
EPS:
-2.86
Net Cash Flow:
$-57.48M
1W Performance:
-3.02%
1M Performance:
-11.36%
6M Performance:
-4.76%
1Y Performance:
+22.00%
Phreesia Inc Stock (PHR) Company Profile
Name
Phreesia Inc
Sector
Industry
Phone
888-654-7473
Address
1521 CONCORD PIKE, WILMINGTON
Phreesia Inc Stock (PHR) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-26-24 | Initiated | Truist | Buy |
Jan-17-24 | Upgrade | DA Davidson | Neutral → Buy |
Jan-03-24 | Initiated | Barclays | Overweight |
Apr-12-23 | Initiated | Stephens | Overweight |
Jan-04-23 | Reiterated | Needham | Buy |
Dec-13-22 | Upgrade | Citigroup | Neutral → Buy |
Dec-09-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
Oct-13-22 | Initiated | DA Davidson | Neutral |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
Apr-14-22 | Initiated | Guggenheim | Buy |
Jan-06-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Dec-02-21 | Initiated | Jefferies | Buy |
Sep-02-21 | Reiterated | Needham | Buy |
Aug-27-21 | Initiated | Canaccord Genuity | Buy |
Jul-13-21 | Initiated | JMP Securities | Mkt Outperform |
Jun-08-21 | Initiated | Berenberg | Buy |
Apr-29-21 | Resumed | JP Morgan | Overweight |
Apr-01-21 | Initiated | Robert W. Baird | Outperform |
Nov-11-20 | Initiated | Stephens | Overweight |
Oct-27-20 | Initiated | Needham | Buy |
Sep-22-20 | Initiated | DA Davidson | Buy |
Jul-14-20 | Initiated | Citigroup | Neutral |
May-15-20 | Initiated | Guggenheim | Buy |
Apr-21-20 | Initiated | RBC Capital Mkts | Sector Perform |
Apr-13-20 | Initiated | SVB Leerink | Outperform |
Jan-31-20 | Initiated | KeyBanc Capital Markets | Overweight |
Jan-09-20 | Initiated | Cantor Fitzgerald | Overweight |
Dec-20-19 | Initiated | Raymond James | Outperform |
Oct-11-19 | Initiated | Robert W. Baird | Outperform |
Aug-13-19 | Initiated | JP Morgan | Overweight |
Aug-12-19 | Initiated | Piper Jaffray | Overweight |
Aug-12-19 | Initiated | Wells Fargo | Outperform |
Aug-12-19 | Initiated | William Blair | Outperform |
Jul-23-19 | Initiated | Chardan Capital Markets | Buy |
View All
Phreesia Inc Stock (PHR) Latest News
Select Equity Group L.P. Has $336,000 Stock Holdings in Phreesia, Inc. (NYSE:PHR) - Defense World
The Latest Analyst Ratings For Phreesia - Benzinga
A company insider recently sold 24 shares of Phreesia Inc [PHR]. Should You Sale? - Knox Daily
Phreesia (NYSE:PHR) Receives Sector Perform Rating from Royal Bank of Canada - MarketBeat
Deerfield Management Company L.P. Series C Takes $4.08 Million Position in Phreesia, Inc. (NYSE:PHR) - MarketBeat
Phreesia Inc (PHR) is looking forward to a strong quarter - SETE News
Phreesia executive sells shares worth over $570 By Investing.com - Investing.com South Africa
Phreesia executive sells shares worth over $570 By Investing.com - Investing.com Australia
Phreesia executive sells shares worth over $570 - Investing.com India
Phreesia executive sells shares worth over $570 By Investing.com - Investing.com Canada
Blair William & Co. IL Sells 27,200 Shares of Phreesia, Inc. (NYSE:PHR) - MarketBeat
Phreesia exec sells over $2,300 in stock amid mandatory policy By Investing.com - Investing.com Australia
Phreesia exec sells over $2,300 in stock amid mandatory policy By Investing.com - Investing.com South Africa
Phreesia exec sells over $2,300 in stock amid mandatory policy By Investing.com - Investing.com Canada
Phreesia exec sells over $2,300 in stock amid mandatory policy - Investing.com
Phreesia exec sells over $2,300 in stock amid mandatory policy - Investing.com India
Phreesia exec sells over $2,300 in stock amid mandatory policy By Investing.com - Investing.com UK
New Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and Adoption - StockTitan
New Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and Adoption - Yahoo Finance
CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence - Business Wire
Patient Intake Software Market Demonstrates a Spectacular Growth by Solutionreach, Phreesia, RevenueWell - openPR
CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence - Yahoo Finance
Phreesia (PHR) Improves Healthcare Outcomes and Expects Growing Clientele - Nasdaq
Phreesia's general counsel sells over $109k in company stock By Investing.com - Investing.com Australia
Phreesia CEO Chaim Indig sells over $123k in company stock - Investing.com
Phreesia executive sells over $42k in company stock - Investing.com
Phreesia's general counsel sells over $109k in company stock - Investing.com India
Phreesia CFO sells over $81k in company stock - Investing.com India
Phreesia, Inc. (NYSE:PHR) Receives $29.42 Average Price Target from Brokerages - MarketBeat
Phreesia CEO Chaim Indig sells over $123k in company stock - Investing.com India
Phreesia COO sells over $73k in company stock By Investing.com - Investing.com Canada
Phreesia's general counsel sells over $109k in company stock By Investing.com - Investing.com Canada
Phreesia COO sells over $73k in company stock - Investing.com
Phreesia CEO Chaim Indig sells over $123k in company stock - Investing.com Australia
Phreesia CFO sells over $81k in company stock By Investing.com - Investing.com Australia
Phreesia CEO Chaim Indig sells over $123k in company stock - Investing.com Canada
Phreesia executive sells shares worth over $17k - Investing.com
Insider Selling: Phreesia, Inc. (NYSE:PHR) Insider Sells 744 Shares of Stock - MarketBeat
Phreesia's general counsel sells over $109k in company stock - Investing.com
Phreesia executive sells shares worth over $17k By Investing.com - Investing.com Canada
Phreesia's general counsel sells over $109k in company stock By Investing.com - Investing.com UK
Phreesia GAAP EPS of -$0.58 beats by $0.10, revenue of $91.62M beats by $1.82M - MSN
Phreesia (NYSE:PHR) Given New $28.00 Price Target at JPMorgan Chase & Co. - Defense World
Phreesia (NYSE:PHR) Price Target Raised to $28.00 - MarketBeat
Truist sees EBITDA strength driving Phreesia stock upside despite slower revenue growth - Investing.com India
Phreesia (NYSE:PHR) Shares Gap Up Following Analyst Upgrade - MarketBeat
Phreesia (NYSE:PHR) Given New $31.00 Price Target at Truist Financial - MarketBeat
Phreesia Second Quarter 2025 Earnings: EPS Beats Expectations - Yahoo Finance
Here's What Analysts Are Forecasting For Phreesia, Inc. (NYSE:PHR) After Its Second-Quarter Results - Simply Wall St
Truist sees EBITDA strength driving Phreesia stock upside despite slower revenue growth - Investing.com
Phreesia (NYSE:PHR) Given Market Outperform Rating at JMP Securities - Defense World
Phreesia Inc Stock (PHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):